Blog

Find out more about what is happening at Cmed

ASCO 2017 Summary
14 Jun

ASCO 2017 Summary

14 Jun 2017

It’s always a pleasure for me to attend the American Society of Clinical Oncology (ASCO) Annual Meeting and this year was no exception. The sheer size and scale of the conference is astounding, with over 35,000 oncology professionals, cancer researchers and patient advocates gathered in Chicago for the most important oncology meeting in the world. The ASCO Annual Meeting not only gets bigger each year, but better. A busy and varied program of informative scientific meetings, educational conferences and professional workshops took place over five days, packed full of people wanting to discuss, debate and listen to the latest research, new treatment breakthroughs, advances in patient care, therapeutic options, ongoing disputes in the field of oncology, etc....

Read post
Cmed shows encapsia® at DIA 2017
12 Jun

Cmed shows encapsia® at DIA 2017

12 Jun 2017

Cmed, an innovative, technology-led oncology CRO, today announced its participation at the DIA Annual Meeting in Chicago, Illinois (June 19-21), where it will show how encapsia® enables faster clinical trial delivery, increased patient safety and better decision making with its’ live, actionable data Insights (Booth 1359). Cmed has considerable expertise in the delivery of complex and demanding clinical trials, including early phase, Proof of Concept, oncology, rare diseases and adaptive studies....

Read post
Cmed shows encapsia® at 2017 ASCO Annual Meeting
19 May

Cmed shows encapsia® at 2017 ASCO Annual Meeting

19 May 2017

Cmed, an innovative technology-led oncology CRO, today announced it will be exhibiting at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois (June 3-5), and showing how encapsia® can help improve patient safety, study conduct and decision making in oncology clinical trials (Booth 23128). Cmed has earned a strong reputation for successfully conducting oncology trials across all phases and in numerous cancer types, including breast, lung, prostate, colorectal and other solid cancers, and haematological malignancies....

Read post
eSource Bootcamp- Wheel of Change
11 May

eSource Bootcamp- Wheel of Change

11 May 2017

4th eSource in Clinical Investigations Annual Bootcamp Sponsors, Sites, and Vendors converged on Philadelphia, PA last week to discuss the current status of eSource (Direct Data Capture) in clinical trials, the hurdles to overcome, and the future. Day one focused on the reasons to do more eSource in trials. Themes included bringing the data collection closer to the patient to reduce errors and how everyone from Investigators, that are currently doing double data entry, to Executive Management, that need to see data and understand the true status of their portfolio at any given time, will benefit....

Read post
eSource Data in Clinical Investigations 2017
25 Apr

eSource Data in Clinical Investigations 2017

25 Apr 2017

Cmed, an innovative technology-led CRO, will present “Why eSource and what will it change? Accessing data in clinical trials” at the 4th Annual eSource Data in Clinical Investigations Conference in Philadelphia at 10.30am on Wednesday May 3rd, 2017. Graham Belgrave, Cmed’s Chief Operations Officer, and Product Manager Jon Carter, will examine the principles of eSource and how it has the potential to be a real “game changer” for trial conduct and for study team roles....

Read post

Want to learn more?

Please feel free to contact us if you would like to learn more about our skills and experience. We are friendly, open and here to help.

Contact us